NCT05024214 2025-05-29Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors3D MedicinesPhase 1/2 Recruiting170 enrolled
NCT05620134 2024-10-15Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerSalubris Biotherapeutics IncPhase 1/2 Active not recruiting263 enrolled